Skip to main content

Table 4 Variability between verses among pediatric rheumatologists and pediatric nephrologists in decision to perform repeat biopsy

From: Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest pediatric nephrology consortium and the childhood arthritis and rheumatology research alliance

 

Pediatric Rheumatologists

Pediatric Nephrologists

Respondents*

109

68

“When do you repeat a kidney biopsy in a patient with proliferative SLE nephritis?

“After the initial induction period, regardless of response to treatment”

7 (6 %)

11 (16 %)

“After the initial induction period, only if there is no response to treatment”

44 (40 %)

31 (46 %)

“After the initial induction period, if there is only partial response to treatment”

26 (24 %)

19 (28 %)

“After remission and before withdrawal of all immunosuppression”

6 (6 %)

3 (4 %)

“After lupus flare with worsening in urine sediment, proteinuria, or kidney function”

75 (69 %)

47 (69 %)

“I do not routinely perform a repeat biopsy in lupus nephritis patients”

35 (32 %)

17 (25 %)

“When do you repeat a kidney biopsy in a patient with membranous SLE nephritis?

“After the initial induction period, regardless of response to treatment”

4 (4 %)

2 (3 %)

“After the initial induction period, only if there is no response to treatment”

33 (31 %)

24 (36 %)

“After the initial induction period, if there is only partial response to treatment”

14 (13 %)

12 (18 %)

“After remission and before withdrawal of all immunosuppression”

6 (6 %)

2 (3 %)

“After lupus flare with worsening in urine sediment, proteinuria, or kidney function”

71 (66 %)

48 (72 %)

“I do not routinely perform a repeat biopsy in lupus nephritis patients”

37 (35 %)

17 (25 %)

  1. *Number and percentage of respondents indicating affirmatively that they would recommend repeat kidney biopsy in patients with pSLE, either for proliferative or membranous LN